 |
Rifampin |
|---|---|
| Trade Name | Rifadin I.V. |
| Orphan Indication | For antituberculosis treatment where use of the oral form of the drug is not feasible |
| USA Market Approval | USA |
| USA Designation Date | 1985-12-09 00:00:00 |
| Sponsor | Hoechst Marion Roussel;P.O. Box 9627;Kansas City, Missouri, 64134 |
